Sort
53,477 grants matching “addiction”
Role of Locus Coeruleus in Response Inhibition
$421,425Gary S. Aston-Jones · Medical University Of South Carolina · R01 · FY2011 · MH
Development and preliminary testing of a peer narrative video intervention for older adults with chronic pain
$421,329Lisa A Uebelacker · Butler Hospital (Providence, Ri) · R01 · FY2024 · AG
Chronic nicotine inhalation increases susceptibility to cardiovascular and pulmonary diseases through inhibition of local compensatory mechanisms
$421,318Jason Davin Gardner · Lsu Health Sciences Center · R01 · FY2018 · HL
Multidisciplinary Training in the Biology of Alcohol Addiction
$421,317Brian A McCool · Wake Forest University Health Sciences · T32 · FY2021 · AA
Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use
$421,290Suzette V Glasner-Edwards · University Of California Los Angeles · R61 · FY2020 · AT
Mechanism of Action of L THP as an Alternative Therapy for Cocaine Addiction
$421,263David Yue-Wei Lee · Mclean Hospital · R01 · FY2016 · AT
Appalachian Tri-State Node
$421,245Dennis C Daley · University Of Pittsburgh At Pittsburgh · U10 · FY2012 · DA
Chemical biology tools for illuminating cannabinoid signaling pathways in opioid use disorder.
$421,200James Allen Frank · Oregon Health & Science University · DP1 · FY2025 · DA
Chemical biology tools for illuminating cannabinoid signaling pathways in opioid use disorder.
$421,200James Allen Frank · Oregon Health & Science University · DP1 · FY2024 · DA
Macromolecular X-ray Data Collection Instrumentation
$421,140Mair E Churchill · University Of Colorado Denver · S10 · FY2014 · OD
Impact of sugars on tobacco product toxicity and abuse liability
$421,132Irina Stepanov · University Of Minnesota · R01 · FY2022 · DA
Microglia and Adolescent Susceptibility to Developing an Alcohol Use Disorder
$421,080Kimberly Nixon · University Of Texas At Austin · R01 · FY2021 · AA
Targeting CDK7 in high-grade serous ovarian carcinoma
$421,071Lin Zhang · University Of Pennsylvania · R01 · FY2024 · CA
Pharmacology of Dopamine Release by Amphetamine
$421,059Margaret E Gnegy · University Of Michigan At Ann Arbor · R01 · FY2016 · DA
Re-engineering Methadone Treatment: A Randomized Clinical Trial
$421,056Robert P Schwartz · Friends Research Institute, Inc. · R01 · FY2014 · DA
Animal models to inform FDA tobacco regulation: Assessing the relative abuse liability of different classes of tobacco products
$421,054Andrew Charles Harris · Hennepin Healthcare Research Institute · R01 · FY2019 · DA
DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCE
$421,044Michael R Bruchas · University Of Washington · R37 · FY2019 · DA
Nicotine and Alcohol Co-Dependence
$420,967Scott C Steffensen · Brigham Young University · R01 · FY2014 · DA
Mechanism of Action of L THP as an Alternative Therapy for Cocaine Addiction
$420,961David Yue-Wei Lee · Mclean Hospital · R01 · FY2013 · AT
Developmental Project 1
$420,949James R McKay · University Of Pennsylvania · P01 · FY2012 · AA
Epigenetic Mechanisms Underpinning Mantle Cell Lymphoma Sensitivity and Resistance to Notch Inhibitors
$420,829Robert Babak Faryabi · University Of Pennsylvania · R01 · FY2022 · CA
Retinoic acid signaling: a novel factor for addiction-related behavior
$420,805Thomas Arthur Green · University Of Texas Med Br Galveston · R01 · FY2020 · DA
COBRE Transitional Center in Neuroscience
$420,758George A Spirou · West Virginia University · P30 · FY2010 · RR
Arkansas ECHO ISPCTN Site (AREIS)
$420,750Tamara Taylor Perry · Arkansas Children'S Hospital Res Inst · UG1 · FY2024 · OD
Arkansas ECHO ISPCTN Site (AREIS)
$420,750Paul M Darden · Arkansas Children'S Hospital Res Inst · UG1 · FY2021 · OD